In a rare admission, a top Chinese disease control expert has reportedly said that their vaccines “offer low protection” against Covid19.
Gao Fu, director of the Chinese Center for Disease Control, and Prevention, said the efficacy rates of these vaccines need improving, and among the strategies being mulled is to “mix them.”
Gao explained that their scientists are currently considering using different vaccines from different technical lines to improve existing efficacy rates of the Chinese vaccines.
“We will solve the issue that current vaccines don’t have very high protection rates,” he was quoted in wire news reports as saying during a conference on immunization strategies in the city of Chengdu last week.
Astoundingly, he praised the benefits of mRNA technology used in the production of Western vaccines like Pfizer and Moderna.
Gao said Chinese experts are still experimenting with vaccines using the mRNA methodology, and that this is still in clinical trials.
China has already distributed hundreds of millions of doses of vaccines to countries all over the globe, including the Philippines.
Despite this negative assessment, Malacanang insists that Sinovac’s Covid19 vaccine is effective against serious illness.
It however failed to address the see-sawing statements made by the Food and Drug Administration (FDA) regarding the administering of Sinovac to senior citizens.
Initially, the FDA said the Sinovac vaccine is not recommended for seniors or persons above the age of 59, and then all of a sudden FDA director Eric Domingo made an about face and declared it is okay since it is the only vaccine available in the country (since all of the high-efficacy brands are being given a hard time to enter the market with all the red tape they are experiencing.)
Photo: Strait Times